Market Access News | pharmaphorum

News

Biogen's new high-dose version of SMA drug Spinraza has started regulatory reviews - but can it help return the drug to growth?

News

A Senate hearing on Robert F Kennedy Jr's nomination as HHS Secretary is set for 29th January, with opposition to Trump's pick seemingly growing.

News

UK study finds adults with ADHD have a big shortfall in life expectancy, raising questions about diagnosis rates and treatment access.

News

Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression.

News

President Trump has started dismantling health legislation introduced under the Biden administration on day one of his new term.

News

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.